Clinical Trial Update: Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists

View source ↗

Summary

This completed decision-impact study evaluates how the DECIPHER genomic classifier influences treatment recommendations by radiation oncologists for prostate ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DECIPHER

Snippet

Sponsor: GenomeDx Biosciences Corp | Conditions: Prostate Cancer | Status: COMPLETED